MX9101035A - Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene - Google Patents

Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene

Info

Publication number
MX9101035A
MX9101035A MX9101035A MX9101035A MX9101035A MX 9101035 A MX9101035 A MX 9101035A MX 9101035 A MX9101035 A MX 9101035A MX 9101035 A MX9101035 A MX 9101035A MX 9101035 A MX9101035 A MX 9101035A
Authority
MX
Mexico
Prior art keywords
quinazolinones
pharmaceutical composition
composition containing
biologically active
biologically
Prior art date
Application number
MX9101035A
Other languages
English (en)
Inventor
Jefferson Ray Mccowan
Kenneth Jeff Thrasher
Melvin Joseph Yu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9101035A publication Critical patent/MX9101035A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX9101035A 1990-09-13 1991-09-11 Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene MX9101035A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/581,943 US5075313A (en) 1990-09-13 1990-09-13 3-aryl-4(3H)quinazolinone CCK antagonists and pharmaceutical formulations thereof

Publications (1)

Publication Number Publication Date
MX9101035A true MX9101035A (es) 1992-05-04

Family

ID=24327210

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9101035A MX9101035A (es) 1990-09-13 1991-09-11 Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene

Country Status (20)

Country Link
US (1) US5075313A (es)
EP (1) EP0475755B1 (es)
JP (1) JPH04247080A (es)
KR (1) KR920006350A (es)
CN (1) CN1059722A (es)
AU (1) AU641043B2 (es)
CA (1) CA2050994A1 (es)
CZ (1) CZ279774B6 (es)
DE (1) DE69113379T2 (es)
ES (1) ES2078455T3 (es)
FI (1) FI914262L (es)
HU (1) HUT59128A (es)
IE (1) IE913217A1 (es)
IL (1) IL99402A0 (es)
MX (1) MX9101035A (es)
NO (1) NO913579L (es)
NZ (1) NZ239712A (es)
PT (1) PT98915A (es)
YU (1) YU151691A (es)
ZA (1) ZA917149B (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5340801A (en) * 1991-05-08 1994-08-23 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having cholecystokinin and gastrin antagonistic properties
US5204354A (en) * 1992-02-14 1993-04-20 Merck & Co., Inc. Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders
DE69318212T2 (de) * 1992-06-05 1998-11-19 Merck Sharp & Dohme Sulfatsalz von einem substituierten Triazol, seine pharmazeutischen Zusammensetzungen und ihre Verwendung in Therapie
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
GB0031315D0 (en) * 2000-12-21 2001-02-07 Glaxo Group Ltd Indole derivatives
SI1413331T1 (sl) 2001-01-26 2008-02-29 Schering Corp Kombinacije fenofibrata peroksisomskega proliferator aktivirajocega receptorja (PPAR) z ezetimib zaviralcem absorpcije sterola za vaskularne indikacije
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
JP4711600B2 (ja) 2001-01-26 2011-06-29 シェーリング コーポレイション シトステロール血症の処置のための置換アゼチジノン化合物の使用
US7132415B2 (en) 2001-09-21 2006-11-07 Schering Corporation Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
CA2504878A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorption inhibitors for the treatment of demyelination
CN1756755A (zh) 2003-03-07 2006-04-05 先灵公司 取代的2－吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
JP4589919B2 (ja) 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
CN100439361C (zh) 2003-03-07 2008-12-03 先灵公司 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7348338B2 (en) * 2003-07-17 2008-03-25 Plexxikon, Inc. PPAR active compounds
JP4845730B2 (ja) * 2003-07-17 2011-12-28 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
GB0319126D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
AU2005311925A1 (en) * 2004-11-30 2006-06-08 Plexxikon, Inc. Indole derivatives for use as PPAR PPAR active compounds
JP2008521831A (ja) * 2004-11-30 2008-06-26 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
KR20080042170A (ko) * 2005-09-07 2008-05-14 플렉시콘, 인코퍼레이티드 Ｐｐａｒ 활성 화합물
JP2009509932A (ja) * 2005-09-07 2009-03-12 プレキシコン，インコーポレーテッド Ｐｐａｒ活性化合物
WO2007056124A2 (en) * 2005-11-04 2007-05-18 Hydra Biosciences, Inc. Compounds for modulating trpv3 function
PE20090159A1 (es) * 2007-03-08 2009-02-21 Plexxikon Inc COMPUESTOS DERIVADOS DE ACIDO INDOL-PROPIONICO COMO MODULADORES PPARs
NZ790364A (en) 2020-01-29 2025-12-19 Kamari Pharma Ltd Compounds and compositions for use in treating skin disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192392A (en) * 1978-12-19 1983-02-15 M Ishikawa 3-(substituted (phenyl or pyridyl)) -3,4-dihydroquinazolin-4-ones
EP0442878A4 (en) * 1988-04-05 1991-10-23 Abbott Laboratories Derivatives of tryptophan as cck antagonists

Also Published As

Publication number Publication date
ES2078455T3 (es) 1995-12-16
DE69113379D1 (de) 1995-11-02
AU641043B2 (en) 1993-09-09
EP0475755A1 (en) 1992-03-18
FI914262A7 (fi) 1992-03-14
DE69113379T2 (de) 1996-03-21
PT98915A (pt) 1992-08-31
AU8382991A (en) 1992-03-19
YU151691A (sh) 1994-01-20
FI914262L (fi) 1992-03-14
IL99402A0 (en) 1992-08-18
IE913217A1 (en) 1992-02-25
NO913579L (no) 1992-03-16
US5075313A (en) 1991-12-24
NZ239712A (en) 1993-06-25
NO913579D0 (no) 1991-09-11
CA2050994A1 (en) 1992-03-14
KR920006350A (ko) 1992-04-27
EP0475755B1 (en) 1995-09-27
CN1059722A (zh) 1992-03-25
JPH04247080A (ja) 1992-09-03
HU912921D0 (en) 1992-01-28
CZ279774B6 (cs) 1995-06-14
HUT59128A (en) 1992-04-28
CS279991A3 (en) 1992-04-15
ZA917149B (en) 1992-05-27
FI914262A0 (fi) 1991-09-10

Similar Documents

Publication Publication Date Title
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
BR1100824A (pt) Composto e composição farmacêutica
MX9202839A (es) 4-aminoquinolinas y composiciones farmaceuticas de las mismas.
DE69233474D1 (de) Pharmazeutische Zusammensetzung enthaltend S-Nitrosoimmunoglobuline und Verwendung davon
FI925661L (fi) Injicerbar farmaceutisk komposition
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
FI945198L (fi) Farmaseuttiset ja muut annosmuodot
DE3486441D1 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
IT9022032A0 (it) L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
ATA129892A (de) Pharmazeutische zusammensetzung
NO930677D0 (no) Farmasoeytiske forbindelser
FI925778A0 (fi) Farmaceutiskt aktiva bensokinazolinfoereningar
DE3879811D1 (de) Pharmazeutische zusammensetzung und ihre verwendung.
KR950701924A (ko) 신규한 생물학적으로 활성인 에부르나메닌 유도체 및 그 유도체가 함유된 약제학적 조성물과 그 제조방법
DE4294862T1 (de) Pharmazeutische Komposition
DE69323568D1 (de) Antimikrobielle Zusammensetzungen und pharmazeutische Präparate hiervon
FI934325A7 (fi) Hyönteismyrkkykoostumus ja hyönteismyrkky-yksiköitä
NO931008D0 (no) Farmasoeytiske forbindelser
KR900012897A (ko) 구아니딘 유도체 및 이를 함유하는 약제학적 조성물
UA26064A1 (uk) Фармацевтичhа композиція
EE9400337A (et) Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused
DE59003130D1 (de) Mikrobizid-Formulierungen und deren Verwendung.
DK0511991T3 (da) Farmaceutisk formulering
NO306381B1 (no) Farmasöytisk ampulle
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner